 |
|
COMMENTS AND OPINIONS
Intralesional Lipolysis With Phosphatidylcholine for the Treatment of Lipomas: Pilot Study
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In 2001, a report on intralesional injection of phosphatidylcholine for the reduction of protuberant lower eyelid fat suggested that fat could be dissolved by this substance. Subsequently, physicians used phosphatidylcholine as a "fat burner" to reduce saddlebag trochanteric bulges (breeches) and pendulous abdomens.1 To prove the ability of phosphatidylcholine to reduce fat, a pilot study for the treatment of lipomas was designed (Table). It was conducted according to good clinical practice guidelines with ethics committee approval. Fifteen volunteers (5 women and 10 men) aged 21 to 64 years (median age, 43.5 years) with 19 lipomas in various body sites were recruited for the study. All sought treatment for functional or aesthetic reasons. At baseline, before the first treatment, and at the end of follow-up (week 12), photographic documentation was performed and ultrasound imaging was used to evaluate 3 dimensions of each lipoma: thickness, length, and diameter at a . . . [Full Text of this Article]
AUTHOR INFORMATION
Daisy Kopera, MD;
Barbara Binder, MD;
Hermann Toplak, MD
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Intralesional Lipolysis With Phosphatidylcholine for the Treatment of Lipomas: Pilot Study--Reply
Kopera
Arch Dermatol 2006;142:1070-1070.
FULL TEXT
Intralesional lipolysis with phosphatidylcholine for the treatment of lipomas: pilot study.
Bechara et al.
Arch Dermatol 2006;142:1069-1070.
FULL TEXT
Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers.
Robinson and Ramos-e-Siliva
Arch Dermatol 2006;142:362-364.
FULL TEXT
|
